Tannin Formulation for Treating Gi Spasms

Liveleaf Holdings LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 11 of these applications claim priority to application 13/726,180, filed Dec 23, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 8,716,352	Tannin Formulation for Treating Gi Spasms Liveleaf Holdings LLC. In force Term ends Dec 23, 2032 · High confidence	Liveleaf Holdings LLC.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 8,946,304	Methods of Treating Malnutrition LiveLeaf, Inc. In force Term ends Dec 23, 2032 · High confidence	LiveLeaf, Inc.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 8,952,072	Tannin Formulation for Treating Malnutrition LiveLeaf, Inc. In force Term ends Dec 23, 2032 · High confidence	LiveLeaf, Inc.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 9,023,895	Methods of Treating Necrotic Enteritis Liveleaf Holdings LLC. In force Term ends Dec 23, 2032 · High confidence	Liveleaf Holdings LLC.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 9,089,596	Methods of Treating Drug Side-Effects That Include a Gastrointestinal Spasm LiveLeaf, Inc. In force Term ends Dec 23, 2032 · High confidence	LiveLeaf, Inc.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 9,408,869	Methods of Treating a Gastrointestinal Spasm Associated with Chemotherapy or Radiation Therapy LiveLeaf, Inc. In force Term ends Dec 23, 2032 · High confidence	LiveLeaf, Inc.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 9,603,871	Methods of Treating Gastroesophageal Reflux Disease Liveleaf Holdings LLC. In force Term ends Dec 23, 2032 · High confidence	Liveleaf Holdings LLC.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 9,603,883	Methods of Inhibiting a Bacterial Virulence in a Subject Liveleaf Holdings LLC. In force Term ends Dec 23, 2032 · High confidence	Liveleaf Holdings LLC.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 9,907,818	Methods of Treating a Treatment-Resistant Gastrointestinal Spasm Liveleaf Holdings LLC. In force Term ends Dec 23, 2032 · High confidence	Liveleaf Holdings LLC.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
US 10,039,784	Methods of Treating a Treatment-Resistant Gastrointestinal Spasm with an Oxidized Tannin Liveleaf Holdings LLC. In force Term ends Dec 23, 2032 · High confidence	Liveleaf Holdings LLC.	In force	Term ends Dec 23, 2032	Term ends Dec 23, 2032	High confidence
10 more patents in this group · Pro

10 of 20 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Pro members see all 20, including 9 expired.

Upgrade to Pro

11 of these are in force and held by Liveleaf Holdings LLC.

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.